Breast Augmentation and Rhinoplasty All-Inclusive Package in Turkey

Questions from you

Use these prompts to assess an individual treatment plan before agreeing to it. They do not promise a particular technique, device or payment arrangement from any provider. BreastAugmentationInTurkey.org is an independent marketing and lead-generation platform, not a healthcare provider or medical-tourism intermediary. An enquiry may be shared with authorised healthcare providers only with your consent.

Which implant is proposed, and which details will my implant card record?

Ask the written plan to identify the fill, shape, surface, volume and profile being considered, along with the planned pocket and incision. Volume and profile should be selected from breast-base dimensions, available tissue cover and the projection under discussion. FDA labelling for legally marketed implants includes device materials and a patient device card. A brand should not be selected from a headline alone; the record should let you identify the device later. For FDA-approved saline implants, a navel incision is not recommended because of rupture and deflation risk. Sources: FDA information for people considering implants, FDA breast implant safety information.

What is the long-term imaging plan for this implant?

Breast implants are not lifetime devices, so the chance of removal, exchange or another operation rises with time and may bring separate costs. Silicone-gel rupture can be silent, whereas saline deflation is usually noticed by a change in size or shape. FDA guidance describes MRI as the most effective test for a silent silicone rupture and ultrasound as an acceptable screen when there are no symptoms. For silicone implants, the FDA labelling schedule is a first ultrasound or MRI at 5–6 years, then every 2–3 years; symptoms or an unclear ultrasound warrant MRI. This surveillance is separate from routine breast-cancer screening. Sources: FDA breast implant safety information, FDA breast implant labelling guidance, ASPS breast implant safety.

Which changes around an implant need assessment, and how would they be investigated?

Contracture is tightening of the scar capsule: Baker I is soft and natural, II slightly firm but natural, III firm and distorted, and IV firm, painful and distorted. Severe III–IV cases may need another operation and contracture can return. Displacement, rupture, swelling, asymmetry or a new lump also need clinical assessment. Persistent swelling or pain may require examination, imaging and fluid or tissue assessment. BIA-ALCL is a lymphoma, not breast cancer; confirmed disease generally requires removal of implant and capsule and some people need oncology treatment. Fatigue, brain fog and joint pain are sometimes called breast implant illness, but its cause is uncertain and removal cannot be promised to resolve it. Other rare capsule-associated malignancy reports are separate safety issues. Source: FDA breast implant safety information.

Where is the incision planned, and what asymmetry or scarring may remain?

The plan should name the incision, pocket and scar position for your anatomy. Existing differences in size, shape or level may not fully disappear. In an exchange, the prior scar is often reused, but its location, thin tissue and the capsule can limit that choice. Scars are permanent and can broaden; a later scar revision should be treated as a separate possibility, not assumed to be included. Source: FDA breast implant safety information.

If a wound concern, or an implant concern when an implant is part of the plan, develops after I return home, who coordinates care and which costs apply?

Before travel, ask in writing where reviews would occur, who handles an urgent concern, and how further treatment and a return journey would be funded. Travel insurance often excludes surgical complications, and a device card or manufacturer warranty does not itself cover clinical care, admission or revision. Seek prompt clinical advice for increasing swelling or bruising, fever, an opening wound, visible implant, or new one-sided fluid or lump. This page makes no promise that a provider pays these items. Sources: NHS advice on cosmetic surgery abroad, FDA information for people considering implants.

How will nasal breathing be assessed before rhinoplasty?

A shape discussion should not replace an airway assessment. Ask the clinician to record the septum, turbinates and internal and external nasal valves separately, and to explain which finding is relevant to you. Source: AAO-HNS rhinoplasty guidance.

How will the planned shape change protect or address breathing?

Reducing the bridge too far can narrow the internal nasal valve, and weakening the tip cartilages can harm both shape and breathing. The written plan should set out cosmetic reduction alongside any septal or valve work, where indicated, so one is not discovered later as a side effect of the other. Source: AAO-HNS rhinoplasty guidance.

If grafting is needed, what material is planned and why?

For a revision, prior operative notes, previous graft position and donor suitability matter. Septal cartilage is usually considered first when available; ear cartilage may suit tip work but can alter ear contour, while rib cartilage can provide more structural support but brings another wound and pain. Ask what material is proposed, why it fits the structural need and what donor-site trade-off applies. Source: AAO-HNS rhinoplasty guidance.

After I return home, what should trigger urgent assessment and how is follow-up arranged?

Confirm in writing the follow-up route, the local emergency pathway and responsibility for additional treatment or travel. NHS advice uses 7–10 days after facial surgery as a travel-planning window, but clearance remains individual. Uncontrolled bleeding, fever, a wound opening, worsening pain, visual change or breathing difficulty require urgent clinical assessment. Photographs can support remote review but do not replace an in-person examination or nasal endoscopy when those are needed. Ask where reviews take place and what a clinic follow-up, further treatment or return journey costs; travel insurance commonly excludes surgical complications. This page does not promise a provider-funded solution. Sources: NHS advice on cosmetic surgery abroad, AAO-HNS rhinoplasty guidance.